Absolute Bioavailability of Breviscapine Sustained Release Tablet in Rabbit

SHEN Teng,Yu Yunqiu,WENG Weiyu,LI Ni,HUANG Zhaochang,CAI Jia,HUANG Jianming

DOI: https://doi.org/10.3969/j.issn.1007-4406.2008.01.007

2008-01-01

Abstract:AIM To investigate the pharmacokinetics of scutellarin after intravenous injection (iv) and oral ad- ministration of breviscapine to rabbits and to study the absolute bioavailability of breviscapine sustained release tablet in rabbits.METHODS Scutellarin and internal standard (IS) baicalin were extracted from plasma by solid-phase extrac- tion using C8 cartridges.The concentration of scutellarin in rabbit plasma after intravenous injection of breviscapine injec- tion was determined by a HPLC-ultraviolet (HPLC-UV) method,and that after oral administration of breviscapine sus- tained release tablet was determined by an HPLC-mass spectrometry (MS) method.RESULTS After intravenous injec- tion of breviscapine injection 25 rng,the concentration-time profiles were fitted to a three-compamnent model,and the main pharmacokinetic parameters were as follows:t_(1/2)pi (0.04±0.01) h,t_(1/2)α(0.32±0.23) h,t_(1/2)β(3.3±1.1) h,and AUC_(0→5h)(12.6±2.3)mg·h·L~(-1).After oral administration of sustained release tablet 120 mg,the concentration-time profiles could not be described by classical compartment model,and the main pharmacokinetic parameters were as fol- lows:ρ_(max) (12.7±12.4)μg·L~(-1),t_(max)(9.3±7.3) h and AUC_(0→24h)(110.9±79.0)μg·h·L~(-1).The absolute bioavail- ability (F) of oral administration was only (0.18±0.15) %.CONCLUSION The absolute bioavailability of breviscap- ine sustained release tablet in rabbits is very low.